Theravance Incorporated

NEW YORK (Reuters) - Stocks ended little changed on Monday, with indexes hovering near record levels as concerns about a correction cut earlier gains that had been prompted by news about a flurry of acquisitions. The Dow and the S&P 500 briefly hit all-...

Por Padraic Halpin y Jessica Toonkel DUBLIN/NUEVA YORK, 20 mayo (Reuters) - Royalty Pharma elevó su oferta hostil por Elan a 12,50 dólares por acción y amenazó con retirar la oferta si los accionistas de Elan aprueban una serie de transacciones...

By Joy Ferguson and Rachelle Kakouris May 20 (IFR) - It's looking like another busy week for high-yield as issuers rush in ahead of the long Memorial Day weekend to take advantage of the current window for issuance at near-record low coupons. A total...

LONDON, May 20 (Reuters) - U.S. investor Royalty Pharma raised its offer to $12.50 per share for Irish drugmaker Elan on Monday, representing a premium of 45 percent to Elan's enterprise value, it said. The company said it was offering $4.6 billion for...

DUBLIN/NEW YORK (Reuters) - Royalty Pharma raised its hostile bid for Elan to $12.50 per share and threatened to withdraw the bid if Elan shareholders approve a series of defensive transactions announced by the Irish drug firm. Royalty Pharma, which buys...

DUBLIN, May 15 (Reuters) - Royalty Pharma last year urged Elan to hold off on a multi-billion dollar drug deal until it had taken the Irish drugmaker private to boost the compensation the firms' executives would receive, Elan said on Wednesday. Royalty...

May 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Yahoo and Microsoft, on Tuesday. HIGHLIGHTS * Yahoo : Goldman Sachs raises target to $30 from $27; rating conviction list buy...

By Rachelle Kakouris NEW YORK, May 13 (IFR) - The high-yield market started where it left off Friday with the new issue window remaining wide open for corporate borrowers across the credit spectrum. Ten new dollar deals entered the pipeline this...

NEW YORK (AP) — Stocks are mixed in midday trading, pausing a record-breaking stock rally even after the government reported that Americans increased spending last month. The Dow fell 22.86, or 0.2 percent, to 15,096 as of 11:50 Eastern Daylight...

Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline. The deal announced Monday will give Elan 21 percent of the future...

Por Caroline Valetkevitch NUEVA YORK (Reuters) - Las acciones cerraron planas el lunes en la bolsa de Nueva York, tomándose un respiro tras trepar a máximos históricos la semana pasada, pero la fortaleza del sector cuidado de la salud ayudó a que los...

May 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including AIG, Carlyle Group and Express Scripts, on Monday. HIGHLIGHTS * AIG : Barclays raises to overweight from equal weight -...